View drug registration information details.

Items	Registration information
ID	1062
No	1062
Brand Name	CADGLIM 2
Ingredients	GLIMEPIRIDE USP 2 MG
Dosage Form	TABLET
Primary Packaging	ALU-ALU BLISTER
Storage	STORE BELOW 30 C
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	Prescription only
ATC Classification	A10BB12
Pharmaceutical Class	ANTIDIABETIC
Indications	FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS, WHEN DIET PHYSICAL EXCERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE
Contraindications	INSULIN DEPENDENT DIABETE, DIABETIC COMA, KETOACIDOCIS, SEVERE RENAL OR HEPATIC FUNCTION DISORDER, HYPERSENSITIVITY,SEVERE RENAL OR HEPATIC FUNCTIONS, PREGNANCY AND LACTATION
Side Effects	MILD HYPERSENSITIVITY REACTION, ALLERGIC VASCULITIS, MODERATE TO SEVERETHROMBOCYTOPENIA, TRANSIENT VISUAL DISTURBANCE
Unit Price
EDL	No
Description	PINK COLORED WITH OCCASIONAL WHITE OR PINK SPECKS ROUND SHAPED, BICONVEX UNCOATED TABLETS PLAIN ON BOTH SIDES
Note
License Owner	IC Pharma Lao Co., Ltd
Manufacturer	CADILA PHARMACEUTICALS LIMITED
Country	INDIA
Import Registration No	MFG/CADILA/16783/B
Import Registration Date	2018-02-14
Activity	CERTIFICATE RELEASED
Applied Date	2021-12-10
FDD Registration No	03 I 5399/23
FDD Registration Date	2023-03-17
Expiry Date	2026-03-16

Back to drug list